Document:

Document

Exhibit 10.20

Five9, Inc.
Non-Employee Director Compensation Policy
Approved:  February 12, 2019 (the “Adoption Date”)

Each member of the Board of Directors (the “Board”) of Five9, Inc. (the “Company”) who is not also serving as an employee of the Company or any of its subsidiaries (each such non-employee member, a “Director”) will receive the following compensation for his or her Board service, unless and until changed by the Board.

Annual Cash Compensation

The cash compensation amounts set forth below are payable in equal quarterly installments, in arrears on the last day of each fiscal quarter in which the service occurred (each, a “Quarter”).  For any partial Quarter of service, the applicable quarterly amount will be pro-rated based on days in service.  All amounts are vested at payment.

		
	1.
	Annual Board Service Retainer:

a.    All Directors: $30,000

2.    Annual Chair Service Fee:
a.    Chairman/Lead Director of the Board: $15,000
b.    Chairman of the Audit Committee: $20,000
c.    Chairman of the Compensation Committee: $10,500
d.    Chairman of the Nominating and Governance Committee: $7,500

3.    Annual Committee Member (non-Chair) Service Fee:
a.    Audit Committee: $7,500
b.    Compensation Committee: $5,000
c.    Nominating and Governance Committee: $3,500

Equity Compensation

The equity compensation set forth below will be granted under the Company’s 2014 Equity Incentive Plan (the “Plan”).  The grant sizes indicated below will be subject to the limitation in the Plan on the number of awards that can be granted in a calendar year to any one individual or director and, for the avoidance of doubt, are converted from dollar amounts to Company shares solely pursuant to the formula in this policy and not pursuant to the formula in the Company’s Equity Award Grant Policy that is applicable to grants to Company employees and consultants.  All unvested outstanding stock awards granted under this policy will become fully vested as of immediately prior to a Change in Control (as defined in the Plan).
    
New Director RSU Grant:  For any individual who first becomes a Director after the date hereof (other than as a result of an employee director transitioning to become a non-employee director, and other than any individual who first becomes a Director at the Company’s Annual Meeting),  on the effective date on which the Director joins the Board (the “Service Effective Date”), he or she will be granted, automatically, and without further action by the Board, an RSU for a number of shares equal to (i) the Pro Rated Amount, divided by (ii) the Fair Market Value (as defined in the Plan) of a share of the Company’s common stock on the date of grant, rounded down for any partial share (the “New Director Grant”).  The New Director Grant will vest in full in one installment on the earlier to occur of (i) the first anniversary of the date of the Company’s last Annual Meeting immediately preceding the date of grant, and (ii) immediately prior to the Company’s next succeeding Annual Meeting after the date of grant, subject to the Director’s continued service through such vesting date. The “Pro Rated Amount” shall mean the product of $180,000 

and a ratio, the numerator of which is twelve (12) minus the number of full months that have elapsed between the date the immediately prior Annual Grants were made to the Company’s current Directors (including such date) and the Service Effective Date (but excluding such date), based on a month of 30 days and with the 15th day being rounded up, and the denominator of which is twelve (12).

Annual RSU Grant:  On the date of each annual meeting of the Company’s stockholders at which directors are regularly elected (each, an “Annual Meeting”), each Director will be granted, automatically, and without further action by the Board, an RSU for a number of shares equal to (i) $180,000, divided by (ii) the Fair Market Value, rounded down for any partial share (the “Annual Grant”).  The Annual Grant will vest in full in one installment on the earlier to occur of (i) the first anniversary of the grant date, and (ii) immediately prior to the Company’s next succeeding Annual Meeting, subject to the Director’s continued service through such vesting date.Exhibit

Exhibit 10.21

Five9, Inc.
2019 Executive Bonus Program

On February 11, 2019, the Compensation Committee of the Board of Directors (the “Compensation Committee”) of Five9, Inc. (the “Company”) approved performance targets for the year ending December 31, 2019 that will be used to determine the amount of cash bonus awards that may be earned, on a quarterly basis, by the Company’s Section 16 officers pursuant to the Company’s 2019 bonus program (the “2019 Bonus Program”).
  
Funding of the 2019 Bonus Program will be based upon the Company’s financial performance and each officer’s individual performance for each quarter in the year ending December 31, 2019, using a weighting of 80% for the Company’s financial performance and 20% for individual performance for each executive officer other than our (i) Chief Executive Officer, (ii) President, and (iii) Chief Marketing Officer. Our Chief Executive Officer’s bonus will be funded 100% based upon the Company’s financial performance. Our President’s bonus will be funded 75% based on sales commissions, 18.75% based on Company’s financial performance, and 6.25% based on his individual performance. Our Chief Marketing Officer’s bonus will be funded 50% based on the Company’s financial performance and 50% based on his individual performance. Financial performance will be based upon the Company’s achievement of predetermined revenue and adjusted EBITDA targets using a weighting of 75% for performance achieved against the revenue target and 25% for performance achieved against the adjusted EBITDA target. Achievement below 90% of the revenue target or 80% of the adjusted EBITDA target would result in no cash payout with respect to such target. Achievement up to 125% of the revenue target would result in increasing payouts up to a maximum payout of 150% of the portion of the target bonus allocated to the revenue target. Achievement up to 150% of the adjusted EBITDA target would result in increasing payouts up to a maximum payout of 150% of the portion of the target bonus allocated to the adjusted EBITDA target. In the event that the Company’s actual adjusted EBITDA is below 80% of the adjusted EBITDA target, the maximum cash payout for achieving the revenue target will be 100% of the revenue target bonus.

Below are the annual target bonus levels under the 2019 Bonus Program for the Company’s Section 16 officers:  
	
							
	 

	 
	 
	 
	 
	 
	 
	 

	Name
	 
	Annual Target Bonus
(USD)
	 
	Annual Target Bonus as a Percentage of Base Salary

	Rowan Trollope
	 
	$
	661,250
	 
	 
	115%

	Barry Zwarenstein
	 
	$
	287,250
	 
	 
	75%

	Daniel Burkland
	 
	$
	325,000
	 
	 
	81%

	Scott Welch
	 
	$
	198,600
	 
	 
	60%

	Ryan Kam
	 
	$
	178,200
	 
	 
	60%

	James Doran
	 
	$
	211,250
	 
	 
	65%

	David Pickering
	 
	$
	201,000
	 
	 
	60%

	Jonathan Rosenberg
	 
	$
	210,000
	 
	 
	60%Exhibit
4(b)(xiv)

 

Lord Blackwell

Chairman

 

17 April 2018

 

Private & Confidential

Ms Amanda Mackenzie OBE

 

Dear Amanda,

 

Non-executive Director Appointment –
Lloyds Banking Group plc

 

Following our recent discussions, I am
pleased to confirm that the Board of Lloyds Banking Group plc (“the Group”) has agreed in principle your appointment
as a non-executive director, subject to references and final confirmation.

 

All directors of the Group also serve on
the subsidiary HBOS Plc Board as well as the two principal subsidiary bank boards of Lloyds Bank plc and Bank of Scotland plc
(which together will comprise the ‘Ring Fenced Bank’ Boards). As discussed, the proposed appointment as a non-executive
director will therefore be to the Group Board, HBOS plc and the Ring Fenced Bank Boards (collectively ‘the Companies’)
These boards will generally meet simultaneously, or on the same date if meeting separately.

 

Your appointments will be subject to the
terms and conditions set out in this letter.

 

		1.	Appointment

 

Your appointment to the boards of the Companies
is expected to commence on October 1st 2018. Your appointment will be for an initial term of three years, expiring
at the Annual General Meeting of the Group (AGM) in 2022. Appointments are reviewable annually and require shareholder approval.
Subject to satisfactory performance and Board approval, you will be invited to stand for annual re-election by shareholders at
the AGM in each year of your appointment.

 

Subject to a review of performance and
the requirements of the Board at the time, non-executive directors may be invited to serve for a further term.

 

Continuation of your appointments is subject
to:

 

		•	approval
                                         by the Group of our certification to the regulators that you are a fit and proper person,
                                         and any approval that may in future be required by the regulators in connection with
                                         roles you take on as a member of the Board You must inform the company of any significant
                                         changes in your personal circumstances which may have an impact on your status;

 

		•	satisfactory
                                         performance and contribution to the Board and any Board committees on which you serve;

    	 

    	

    

		•	election
                                         and re-election as a director by the company’s shareholders in general meeting
                                         as required by the company’s articles of association and codes to which the company
                                         subscribes, in particular, the Financial Reporting Council’s UK Corporate Governance
                                         Code.

 

		2.	Termination

 

Once appointed, you will cease to hold
the office of director if:

 

		(i)	you resign from your appointment or
                                         choose not to stand for re-election;

 

		(ii)	the company terminates your appointment
                                         or chooses not to propose you for re-election;

 

		(iii)	shareholders fail to elect or re-elect
                                         you;

 

		(iv)	you fail to meet, on an ongoing basis,
                                         the standards expected of a person performing your role; or

 

		(v)	the articles of association or any law
                                         or regulation prevents you from continuing in office.

 

In the case of (i) and (ii) above, there
is no entitlement to notice or to compensation for loss of office. However, the company will endeavor to give you reasonable notice
where appropriate. You are requested to make the Chairman aware of any intention not to seek re-election so that the board can
plan for orderly succession.

 

In the case of termination under (iii),
(iv) or (v) above, your appointment will terminate automatically with immediate effect and without compensation.

 

		3.	Board Committees

 

In addition to your appointment as a non-executive
director you will be required to serve on at least two Group/Ring Fenced Bank Board Committees which may be subject to rotation.
Initially, it is proposed you serve as:

 

		•	Member,
                                         Risk Committee

 

		•	Member,
                                         Responsible Business Committee

 

You may also be required to serve on sub-committees
of these Board committees and ad hoc Board Committees established from time to time for a specific purpose.

 

		4.	Role and Responsibilities

 

Your duties will be those required of a
non-executive director. Non-executive directors have the same legal responsibilities as other directors.

 

The Board is collectively responsible for
promoting the success of the company by directing the company’s affairs. As members of the unitary board, all directors
are required to:

 

		•	provide
                                         entrepreneurial leadership of the company within a framework of prudent and effective
                                         controls which enable risk to be assessed and managed.

 

		•	set
                                         the company’s strategic aims, ensure that the necessary financial and human resources
                                         are in place for the company to meet its objectives, and review management performance;
                                         and

 

		•	set
                                         the company’s values and standards and ensure that its obligations to its shareholders
                                         and others are understood and met.

 

In addition, as a member of the Ring Fenced
Bank Boards and Committees you will have responsibility with other directors of ensuring effective governance of the Ring Fenced

 

2

    	 

    	

    

Banks, including identifying and addressing any potential conflicts of interest between the Ring Fenced Bank and other group entities
in a way that ensures the integrity of the Ring Fencing Scheme is upheld.

 

Your more specific responsibilities and
accountabilities are reflected in the group’s wider governance framework and will include, to the extent relevant, any responsibilities
prescribed pursuant to UK regulation and as notified to the PRA and/or FCA, details of which are available from the Company secretary.

 

		5.	Time Commitment

 

As a non-executive director, you are required
to devote such time as is necessary for the effective discharge of your duties. The likely minimum time commitment for your role
is approximately 35 – 40 days per annum which is made up as follows:

 

	•	Base time commitment for LBG non-executive directors:	c.25 - 28 days
	•	Additional time for membership of Risk Committee	c.5- 6 days
	•	Additional time for membership of Responsible Business Committee	c.5- 6 days

 

The estimated time commitment includes
scheduled Board and Committee meetings relevant to your role, plus strategy sessions (including a 2 - 3 day offsite meeting),
attendance at the AGM and preparation for meetings. A schedule of Board and committee meetings will be included in your appointment
pack.

 

The above minimum time commitment is based
on planned events. From time to time, you may be required to attend meetings at short notice. In such cases, you will be required
to make yourself available as appropriate.

 

In your capacity as a director of Lloyds
Banking Group plc or a s a director of the Ring Fenced Banks you may be required to attend or represent the Group at meetings
with the Regulators, the Government, investors or other third parties as appropriate.

 

Depending on your other commitments, you
may be expected to relinquish other appointments to ensure that you can meet the legal and time commitments of the role. Legislation
limits a director of a financial services company to holding a maximum of four non-executive director roles.

 

By accepting this appointment, you confirm
that you are able to allocate sufficient time to meet the expectations of your role to the satisfaction of the board.

 

The agreement of the Chairman should be
sought before accepting additional commitments in order to discuss whether they might affect your ability to meet the time commitments
necessary to discharge your duties and enable potential conflict issues to be identified and resolved.

 

		6.	Fees and Expenses

 

The following annual fees are payable in
respect of your appointment:

 

	•	Non-executive base fee	 	£ 78,000
	•	Additional fee for membership of Risk Committee	 	£ 32,650
	•	Additional fee for membership of Responsible Business Committee	 	£15,300
	 	 	 	 
	Total fees payable:	 	£125,950

 

3

    	 

    	

    

You will also be entitled to claim for
reimbursement of reasonable expenses incurred in the course of your duties as a Director so long as these conform to the expenses
policy agreed by the Board.

 

		7.	Outside Interests

 

It is accepted and acknowledged that you
have business interests other than those of the company. As a condition of your appointment you are required to declare any such
directorships, appointments and interests to the board in writing. If you take on any additional business interests or become
aware of any potential conflicts of interest, these must be disclosed to the board as soon as they arise or become known to you.
If at any time you are considering acquiring any new interest which might give rise to a conflict of interest with the company
you must first discuss the matter with the Chairman and obtain a resolution of the board authorising such interest. Regardless
of any approval given in relation to outside interests, it is your responsibility to ensure that you can meet the time commitment
required by the role.

 

		8.	Confidentiality

 

You will not use or disclose to any person,
firm or organisation (except as required by law or to carry out your duties under this letter) any trade secrets, know-how, business
information or other private or confidential information relating to the business, finances or affairs of the company or any member
of the Lloyds Banking Group, or any customer of the company or any other information provided on the basis that it is confidential.
You will use your best endeavours to prevent the unauthorised use or disclosure of any such information.

 

This restriction will continue to apply
after your appointment ends without limit in time but will not apply to information which becomes public, unless through unauthorised
disclosure by you. After your appointment ends you will return all documents and information (whether written, visual or electronic)
under your control which belong to the company or any member of the Group.

 

Your attention is also drawn to the requirements
under both legislation and regulation relating to the disclosure of price sensitive information. You should avoid making any statements
or engaging in any dealings that might contravene these requirements. The Company Secretary can provide further information and
advice on these matters if required. Company policy is that all external communication on company affairs is restricted to the
Chairman, Chief Executive and Corporate Affairs Director only.

 

		9.	Induction

 

Following appointment, the company will
provide further tailored induction to the extent required. You are entitled to request any additional information or briefings
to assist you in the execution of your duties.

 

		10.	Evaluation and review of performance

 

The performance of individual directors
and the board and its committees is evaluated annually. In the interim, if there are any matters which you wish to discuss in
relation to your role, please feel free to contact me.

 

		11.	Directors’ Liability
                                         Indemnity and Insurance

 

To the extent permitted by law, directors
are entitled to be indemnified by the company against all costs and liabilities incurred by them in execution of their duties.
A deed of indemnity is included in your appointment pack for signature and return.

 

You will also have the benefit of any directors’
and officers’ insurance cover maintained from time to time by the company (but this shall not oblige the company to maintain
any such cover either at all, or on current terms).

 

4

    	 

    	

    

		13.	Independent Professional Advice

 

Occasions may arise when you consider that
you need professional advice in the furtherance of your duties as a director and it will be appropriate for you to consult independent
advisers at the company’s expense. The company will reimburse the full cost of expenditure incurred.

 

		14.	Disclosure and Dealings in
                                         Shares

 

The company may be required to include
in its annual accounts a note of any material interest that a director may have in any transaction or arrangement that the company
has entered into. You must disclose any such interest as soon as possible but no later than the board meeting at which the transaction
or arrangement is first discussed so that the Board can note your interest and, if appropriate, approve any conflicts. A general
notice that you are interested in any contracts with a particular person, firm or company is acceptable.

 

During the continuation of your appointment
you will be expected to comply (and to procure that your spouse and any connected persons comply) where relevant with any rule
of law or regulation of any competent authority or of the company from time to time in force in relation to dealings in shares,
debentures and other securities of the company and the unpublished price sensitive information affecting the shares, debentures
and other securities of the company.

 

Details of the procedure for dealing in
shares, together with explanatory notes on the code of market conduct/model code, will be in your appointment pack.

 

		15.	Shareholdings

 

All directors are encouraged to hold shares
in the company. If you would like to receive whole or part of your monthly fee in shares, we would be happy to make the necessary
arrangements for you.

 

Please acknowledge receipt and acceptance
of the above terms by signing and returning the enclosed copy of this letter.

 

Please do not hesitate to contact me for
any assistance in any matters during the term of your appointment. I will write formally again at the time the appointment is
confirmed by the Board and will look forward to welcoming you to the Group.

 

Best regards,

 

/s/ Norman Blackwell

 

I acknowledge receipt of the letter dated
17 April, 2018 of which this is a copy and accept the proposed terms of appointment.

 

	Signed	 	/s/ Amanda Mackenzie	 

 

	Date	 	22nd April 2018	 

 

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}]]